Background and objective: There are several reports of sub‐standard and counterfeit
antimalarial drugs circulating in the markets of developing countries; we aimed to review the …

Background There are concerns about the quality of medicines available in low-and middle-
income countries (LMIC) to manage hemorrhage, pre-eclampsia/eclampsia and sepsis. We …

Abstract During the period 2011-2015, the Drug Analysis and Research Unit (DARU)
analyzed 1972 drug samples. The samples consisted of 21.5% locally manufactured and …

Abstract During the period 2006-2010, the Drug Analysis and Research Unit analyzed 583
samples. The samples comprised 50.6% local and 49.4% imported products. Samples were …

The quality of 14 metformin hydrochloride tablet products locally available in the Kenyan
market is reported. The samples composed both 500 mg and 850 mg strengths. The …

Background: The main strategy for rolling back malaria in Africa is prompt, presumptive
treatment of fever among those at risk. Most fevers in Africa are treated first with antipyretic or …

Abstract During the 2013-2017 period, the MEDS laboratory received and processed 6853
samples. Samples were sourced from Kenya and other sub-Saharan Africa countries. The …

Abstract During the period 2002–2005, the National Quality Control Laboratory analysed
229 samples of antimalarial drugs. In 2002, 42% of these products failed to comply with …

During the five-year period covering 2016-2020, the Drug Analysis and Research Unit
(DARU) received and processed 326 drug samples. Of these samples, 32.5% were locally …

My profound and sincere gratitude go to my supervisors, Prof. Nicholas Gikonyo and Prof.
Gilbert Kokwaro, for the assistance, support and guidance given to me in this work from …